[46] The anterior segment of the eye is particularly susceptible to oxidative stress due to constant exposure of the eye to radiation, atmosphere oxygen, environmental chemicals, and physical abrasions
Results confirmed positive impact of GLP-1 receptor agonists on MACE outcomes in patients with T2D but also revealed promising trends regarding heart failure outcomes in terms of reduced rate of heart failure-related events ( In conclusion, GLP-1 receptor agonists show potential in heart failure management through their multiple mechanisms of action, including direct cardioprotective effects, vasodilation, natriuresis, and glucose and weight control

Extra caution is advised in people with: A history of pancreatitis Severe acidity or gastroparesis (very slow stomach emptying) Known gallstones or gallbladder disease Advanced kidney disease Significant diabetic eye disease (retinopathy) A very low BMI or a history of eating disorders Pregnancy, plans to become pregnant, or breastfeeding, since some GLP-1 medicines stay in the body for several weeks after stopping Significant depression, who should be monitored carefully Upcoming surgery, endoscopy, or a procedure needing anaesthesia or sedation, since delayed stomach emptying can raise aspiration risk and temporary stopping may be advised How GLP-1 side effects usually progress: a typical timeline Every person is different, but clinical practice and studies suggest a rough pattern [6]: First 2 to 6 weeks: nausea, early fullness, and constipation are most common
Known for her thorough approach and warm demeanor, Dr
Sirtori CR, Bolme P, Azarnoff DL
Table 3 Group differences in % change from previous timepoint including timepoints 1, 2, and 3 (main effects for the group)